FLAGSHIP HARBOR ADVISORS, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
FLAGSHIP HARBOR ADVISORS, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$7,417
-93.7%
10,550
+49.2%
0.00%
-93.8%
Q3 2020$117,000
-28.2%
7,0700.0%0.02%
-33.3%
Q2 2020$163,000
+29.4%
7,0700.0%0.02%
-4.0%
Q1 2020$126,000
+31.2%
7,070
+59.1%
0.02%
+47.1%
Q4 2019$96,000
-17.9%
4,445
-31.4%
0.02%
-26.1%
Q3 2019$117,000
-49.1%
6,4750.0%0.02%
-52.1%
Q2 2019$230,000
+22.3%
6,475
+15.5%
0.05%
+23.1%
Q1 2019$188,000
+20.5%
5,607
+17.5%
0.04%
+2.6%
Q4 2018$156,000
-34.2%
4,772
+14.1%
0.04%
-13.6%
Q3 2018$237,000
+66.9%
4,182
+43.6%
0.04%
+57.1%
Q2 2018$142,0002,9130.03%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2018
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders